{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:26:39Z","timestamp":1785583599893,"version":"3.56.0"},"reference-count":48,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019R1C1C1005172,"],"award-info":[{"award-number":["2019R1C1C1005172,"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2019M3A9H1103690"],"award-info":[{"award-number":["2019M3A9H1103690"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A2C1010962"],"award-info":[{"award-number":["2020R1A2C1010962"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017M3A9G8083382"],"award-info":[{"award-number":["2017M3A9G8083382"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020M3A9D3038894"],"award-info":[{"award-number":["2020M3A9D3038894"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Psoriasis is a chronic inflammatory skin disease accompanied by excessive keratinocyte proliferation. Corticosteroids, vitamin D3 analogs, and calcineurin inhibitors, which are used to treat psoriasis, have diverse adverse effects, whereas natural products are popular due to their high efficiency and relatively low toxicity. The roots of the Cudrania tricuspidata (C. tricuspidata) are known to have diverse pharmacological effects, among which the anti-inflammatory effect is reported as a potential therapeutic agent in skin cells. Nevertheless, its effectiveness against skin diseases, especially psoriasis, is not fully elucidated. Here, we investigated the effect of cudraxanthone D (CD), extracted from the roots the C. tricuspidata Bureau, on psoriasis using an imiquimod (IMQ)-induced mouse model and the tumor necrosis factor (TNF)-\u03b1\/interferon (IFN)-\u03b3-activated keratinocytes. IMQ was topically applied to the back skin of C57BL\/6 mice for seven consecutive days, and the mice were orally administered with CD. This resulted in reduced psoriatic characteristics, such as the skin thickness and Psoriasis Area Severity Index score, and the infiltration of neutrophils in IMQ-induced skin. CD inhibited the serum levels of TNF-\u03b1, immunoglobulin G2a, and myeloperoxidase, and the expression of Th1\/Th17 cells in splenocytes. In TNF-\u03b1\/IFN-\u03b3-activated keratinocytes, CD reduced the expressions of CCL17, IL-1\u03b2, IL-6, and IL-8 by inhibiting the phosphorylation of STAT1 and the nuclear translocation of NF-kB. Taken together, these results suggest that CD could be a potential drug candidate for the treatment of psoriasis.<\/jats:p>","DOI":"10.3390\/molecules26196086","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:37:29Z","timestamp":1633901849000},"page":"6086","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cudraxanthone D Ameliorates Psoriasis-like Skin Inflammation in an Imiquimod-Induced Mouse Model via Inhibiting the Inflammatory Signaling Pathways"],"prefix":"10.3390","volume":"26","author":[{"given":"Namkyung","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9949-6477","authenticated-orcid":false,"given":"Soyoung","family":"Lee","sequence":"additional","affiliation":[{"name":"Immunoregulatory Materials Research Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup 28116, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjoo","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Ae","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Hyun","family":"Jang","sequence":"additional","affiliation":[{"name":"Departments of Dermatology, School of Medicine, Kyungpook National University, Daegu 41944, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil-Saeng","family":"Jeong","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Chungnam National University, Daejeon 34134, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Cell & Matrix Research Institute, School of Medicine, Kyungpook National University, Daegu 41944, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of Psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7931031","DOI":"10.1155\/2018\/7931031","article-title":"Antipsoriatic Effects of Wannachawee Recipe on Imiquimod-Induced Psoriasis-Like Dermatitis in BALB\/c Mice","volume":"2018","author":"Wongnoppavich","year":"2018","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3389\/fimmu.2018.01549","article-title":"The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/0019-5154.94272","article-title":"The role of cytokines in the pathomechanism of cutaneous disorders","volume":"57","author":"Coondoo","year":"2012","journal-title":"Indian J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jaad.2009.03.027","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents","volume":"61","author":"Menter","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/bjd.12393","article-title":"Topical treatments for chronic plaque psoriasis of the scalp: A systematic review","volume":"169","author":"Mason","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/ijd.12790","article-title":"The role of vitamin D in psoriasis: A review","volume":"54","author":"Soleymani","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"ref_11","first-page":"153","article-title":"Clinical and economic review of secukinumab for moderate-to-severe plaque psoriasis","volume":"16","author":"Wong","year":"2016","journal-title":"Expert Rev. Pharm. Outcomes Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/1744666X.2019.1559730","article-title":"Ixekizumab for the treatment of psoriasis: An update on new data since first approval","volume":"15","author":"Blegvad","year":"2018","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/187153012802002901","article-title":"Classical to current approach for treatment of psoriasis: A review","volume":"12","author":"Rahman","year":"2012","journal-title":"Endocrine Metab. Immune Disord. Drug Targets"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"644952","DOI":"10.3389\/fphar.2021.644952","article-title":"Advances in the Application of Natural Products and the Novel Drug Delivery Systems for Psoriasis","volume":"12","author":"Xie","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ptr.3577","article-title":"The Fruits of Cudrania tricuspidata Suppress Development of Atopic Dermatitis in NC\/Nga Mice","volume":"26","author":"Lee","year":"2011","journal-title":"Phytother. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"31807","DOI":"10.1039\/C7RA04322H","article-title":"Cudrania tricuspidata: An updated review on ethnomedicine, phytochemistry and pharmacology","volume":"7","author":"Xin","year":"2017","journal-title":"RSC Adv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2018.12.1011","article-title":"Regulatory cells in the skin: Pathophysiologic role and potential targets for anti-inflammatory therapies","volume":"143","author":"Uttarkar","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ko, W., Kim, N., Lee, H., Woo, E.-R., Kim, Y.-C., Oh, H., and Lee, D.-S. (2021). Anti-Inflammatory Effects of Compounds from Cudrania tricuspidata in HaCaT Human Keratinocytes. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147472"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Feng, Z., Lu, X., Gan, L., Zhang, Q., and Lin, L. (2020). Xanthones, A Promising Anti-Inflammatory Scaffold: Structure, Activity, and Drug Likeness Analysis. Molecules, 25.","DOI":"10.3390\/molecules25030598"},{"key":"ref_20","first-page":"59","article-title":"Isolation and Quantitative Analysis of Cudratricusxanthone A and Cudraxanthone D from Roots of Cudrania tricuspidata Bureau","volume":"50","author":"Park","year":"2019","journal-title":"Korean J. Pharmacogn."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23\/IL-17 Axis","volume":"182","author":"Mourits","year":"2009","journal-title":"J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"ii65","DOI":"10.1136\/ard.2004.031237","article-title":"Psoriasis assessment tools in clinical trials","volume":"64","author":"Feldman","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1038\/emm.2017.81","article-title":"Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice","volume":"49","author":"Jeon","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"435","DOI":"10.5114\/ada.2016.63882","article-title":"Contribution of myeloperoxidase and inducible nitric oxide synthase to pathogenesis of psoriasis","volume":"33","author":"Dilek","year":"2016","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"467541","DOI":"10.1155\/2014\/467541","article-title":"Serum Levels of TNF-\u03b1, IL-12\/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease Severity","volume":"2014","author":"Kyriakou","year":"2014","journal-title":"J. Immunol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3389\/fimmu.2019.02376","article-title":"Neutrophils in Psoriasis","volume":"10","author":"Chiang","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_27","first-page":"544","article-title":"[Myeloperoxidase (MPO) as a marker of neutrophil influx into nasal mucosa after recombinant IL-8 challenge]","volume":"70","author":"Kupczyk","year":"2002","journal-title":"Pneumonol. Alergol. Polska"},{"key":"ref_28","first-page":"209","article-title":"Expression of CD11b and CD18 on polymorphonuclear neutrophils stimulated with interleukin-2","volume":"39","author":"Ebaid","year":"2014","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1038\/s41467-020-16596-9","article-title":"Durable and controlled depletion of neutrophils in mice","volume":"11","author":"Boivin","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jaad.2008.10.062","article-title":"Trends in incidence of adult-onset psoriasis over three decades: A population-based study","volume":"60","author":"Icen","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kamiya, K., Kishimoto, M., Sugai, J., Komine, M., and Ohtsuki, M. (2019). Risk Factors for the Development of Psoriasis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184347"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"561018","DOI":"10.1155\/2012\/561018","article-title":"Mechanisms of Action of Topical Corticosteroids in Psoriasis","volume":"2012","author":"Uva","year":"2012","journal-title":"Int. J. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Shenefelt, P.D. (2011). Chapter 18 herbal treatment for dermatologic disorders. Herbal Medicine: Biomolecular and Clinical Aspects, CRC Press. [2nd ed.].","DOI":"10.1201\/b10787-19"},{"key":"ref_34","first-page":"1144","article-title":"Cudrania tricuspidata Fruit Extract Ameliorates Free Fatty Acid-induced Lipid Accumulation in HepG2 Cells","volume":"29","author":"Lee","year":"2019","journal-title":"J. Life Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1142\/S0192415X15500810","article-title":"Cudraxanthone H Induces Growth Inhibition and Apoptosis in Oral Cancer Cells via NF-\u03baB and PIN1 Pathways","volume":"43","author":"Lee","year":"2015","journal-title":"Am. J. Chin. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1055\/s-2008-1081315","article-title":"Cudratricusxanthone A Protects Mouse Hippocampal Cells against Glutamate-Induced Neurotoxicity via the Induction of Heme Oxygenase-1","volume":"74","author":"Jeong","year":"2008","journal-title":"Planta Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1016\/j.bmcl.2006.08.032","article-title":"Anti-atherosclerotic and anti-inflammatory activities of catecholic xanthones and flavonoids isolated from Cudrania tricuspidata","volume":"16","author":"Park","year":"2006","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5213028","DOI":"10.1155\/2019\/5213028","article-title":"Cudraxanthone D Regulates Epithelial-Mesenchymal Transition by Autophagy Inhibition in Oral Squamous Cell Carcinoma Cell Lines","volume":"2019","author":"Yu","year":"2019","journal-title":"Evid. -Based Complement. Altern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Jabeen, M., Boisgard, A.-S., Danoy, A., El Kholti, N., Salvi, J.-P., Boulieu, R., Fromy, B., Verrier, B., and Lamrayah, M. (2020). Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12090789"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","article-title":"Cytokines in psoriasis","volume":"73","author":"Baliwag","year":"2015","journal-title":"Cytokine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1155\/2013\/856056","article-title":"Serum Levels of Selected Th17 and Th22 Cytokines in Psoriatic Patients","volume":"35","author":"Kowal","year":"2013","journal-title":"Dis. Markers"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.clindermatol.2007.08.012","article-title":"Immunopathogenesis and role of T cells in psoriasis","volume":"25","author":"Ghoreschi","year":"2007","journal-title":"Clin. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Nunes, A., Marto, J., Gon\u00e7alves, L.M., Sim\u00f5es, S., F\u00e9lix, R., Ascenso, A., Lopes, F., and Ribeiro, H.M. (2020). Novel and Modified Neutrophil Elastase Inhibitor Loaded in Topical Formulations for Psoriasis Management. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12040358"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00136-8","article-title":"Keratinocytes and cytokines","volume":"88","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000495291","article-title":"Psoriasis: Keratinocytes or Immune Cells\u2014Which Is the Trigger?","volume":"235","author":"Benhadou","year":"2018","journal-title":"Dermatology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.bor.0000160781.07174.db","article-title":"New strategies for immunosuppression: Interfering with cytokines by targeting the Jak\/Stat pathway","volume":"17","author":"Park","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-\u03baB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri1703","article-title":"NF-\u03baB: Linking inflammation and immunity to cancer development and progression","volume":"5","author":"Karin","year":"2005","journal-title":"Nat. Rev. Immunol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/19\/6086\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:10:41Z","timestamp":1760166641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/19\/6086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":48,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["molecules26196086"],"URL":"https:\/\/doi.org\/10.3390\/molecules26196086","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]}}}